首页> 外国专利> COMBINED PHARMACEUTICAL COMPOSITION FOR TREATMENT arterial hypertension congestive heart failure and chronic heart failure

COMBINED PHARMACEUTICAL COMPOSITION FOR TREATMENT arterial hypertension congestive heart failure and chronic heart failure

机译:药物组合物治疗动脉高血压充血性心力衰竭和慢性心力衰竭

摘要

1. A pharmaceutical composition for treating cardiovascular diseases in a solid dosage form which comprises ramipril in a therapeutically effective amount of the combined stabilizer, filler, binder, disintegrant and lubricant, characterized in that it further comprises indapamid.2. A pharmaceutical composition according to claim 1, characterized in that it contains as stabilizer a combination of sodium hydrogen carbonate and the colloidal silicon dioxide gidrofobnogo.3. A pharmaceutical composition according to claim 2, characterized in that it comprises additionally krasitel.4. A pharmaceutical composition according to claim 3, characterized in that it comprises as a colorant Iron oxide yellow or iron oxide krasnyy5. A pharmaceutical composition according to claim 3, characterized in that it comprises ramipril, indapamide, sodium hydrogencarbonate and hydrophobic colloidal silica in the following proportion, mass.ch.Ramipril - 1,0Indapamid - sodium 0,24-0,37Gidrokarbonat - 0.04- 0,72Dioksid hydrophobic colloidal silica - 0,08-1,66. A pharmaceutical composition according to claim 5, characterized in that it comprises as filler the combination of lactose monohydrate and microcrystalline cellulose as the binder hypromellose as sodium croscarmellose disintegrant, and as a lubricant and a glidant comprises lubrikant.7. A pharmaceutical composition according to claim 6, characterized in that it is made in the form of a tablet.
机译:1.一种用于治疗心血管疾病的固体剂型的药物组合物,其包含雷米普利和治疗有效量的稳定剂,填充剂,粘合剂,崩解剂和润滑剂的组合,其特征在于,其还包含吲达帕米。 2.根据权利要求1的药物组合物,其特征在于它含有碳酸氢钠和胶体二氧化硅gidrofobnogo 3的组合作为稳定剂。 3.根据权利要求2的药物组合物,其特征在于它另外包含krasitel.4。 4.根据权利要求3的药物组合物,其特征在于它包含氧化铁黄或氧化铁krasnyy5作为着色剂。 4.根据权利要求3的药物组合物,其特征在于它包含雷米普利,吲达帕酰胺,碳酸氢钠和疏水性胶体二氧化硅,其质量比例如下:ch.Ramipril-1,0Indapamid-0,24-0,37 Gidrokarbonat-0.04- 0 ,72Dioksid疏水胶体二氧化硅-0,08-1,66。 6.根据权利要求5所述的药物组合物,其特征在于,其包含乳糖一水合物和微晶纤维素的组合作为填充剂,作为羟丙甲纤维素钠崩解剂作为粘合剂羟丙甲纤维素,并且作为润滑剂和助流剂包括润滑剂7。 7.根据权利要求6所述的药物组合物,其特征在于,其被制成片剂形式。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号